These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 14522359)

  • 21. Cannabinoid CB1 receptor antagonist rimonabant disrupts nicotine reward-associated memory in rats.
    Fang Q; Li FQ; Li YQ; Xue YX; He YY; Liu JF; Lu L; Wang JS
    Pharmacol Biochem Behav; 2011 Oct; 99(4):738-42. PubMed ID: 21722663
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Delta 9-tetrahydrocannabinol impairs spatial memory through a cannabinoid receptor mechanism.
    Lichtman AH; Martin BR
    Psychopharmacology (Berl); 1996 Jul; 126(2):125-31. PubMed ID: 8856831
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Medial prefrontal cannabinoid CB1 receptors modulate consolidation and extinction of cocaine-associated memory in mice.
    Hu SS; Liu YW; Yu L
    Psychopharmacology (Berl); 2015 May; 232(10):1803-15. PubMed ID: 25420608
    [TBL] [Abstract][Full Text] [Related]  

  • 24. AM251, cannabinoids receptors ligand, improves recognition memory in rats.
    Bialuk I; Winnicka MM
    Pharmacol Rep; 2011; 63(3):670-9. PubMed ID: 21857077
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The disruptive effects of the CB1 receptor antagonist rimonabant on extinction learning in mice are task-specific.
    Niyuhire F; Varvel SA; Thorpe AJ; Stokes RJ; Wiley JL; Lichtman AH
    Psychopharmacology (Berl); 2007 Apr; 191(2):223-31. PubMed ID: 17211653
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Blockade of cannabinoid CB1 receptors alters contextual learning and memory.
    Arenos JD; Musty RE; Bucci DJ
    Eur J Pharmacol; 2006 Jun; 539(3):177-83. PubMed ID: 16716290
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Discriminative stimulus effects of BAY 38-7271, a novel cannabinoid receptor agonist.
    De Vry J; Rüdiger Jentzsch K
    Eur J Pharmacol; 2002 Dec; 457(2-3):147-52. PubMed ID: 12464360
    [TBL] [Abstract][Full Text] [Related]  

  • 28. SLV330, a cannabinoid CB1 receptor antagonist, ameliorates deficits in the T-maze, object recognition and Social Recognition Tasks in rodents.
    de Bruin NM; Prickaerts J; Lange JH; Akkerman S; Andriambeloson E; de Haan M; Wijnen J; van Drimmelen M; Hissink E; Heijink L; Kruse CG
    Neurobiol Learn Mem; 2010 May; 93(4):522-31. PubMed ID: 20132903
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The CB1 cannabinoid receptor antagonist rimonabant chronically prevents the nicotine-induced relapse to alcohol.
    López-Moreno JA; González-Cuevas G; Navarro M
    Neurobiol Dis; 2007 Feb; 25(2):274-83. PubMed ID: 17067804
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Alterations in behavioral flexibility by cannabinoid CB1 receptor agonists and antagonists.
    Hill MN; Froese LM; Morrish AC; Sun JC; Floresco SB
    Psychopharmacology (Berl); 2006 Aug; 187(2):245-59. PubMed ID: 16752140
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Significance of cannabinoid CB1 receptors in improgan antinociception.
    Gehani NC; Nalwalk JW; Razdan RK; Martin BR; Sun X; Wentland M; Abood ME; Hough LB
    J Pain; 2007 Nov; 8(11):850-60. PubMed ID: 17644043
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The cannabinoid CB1 receptor antagonist AM251 does not modify methamphetamine reinstatement of responding.
    Boctor SY; Martinez JL; Koek W; France CP
    Eur J Pharmacol; 2007 Sep; 571(1):39-43. PubMed ID: 17628534
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of rimonabant, a selective cannabinoid CB1 receptor antagonist, in a rat model of Parkinson's disease.
    González S; Scorticati C; García-Arencibia M; de Miguel R; Ramos JA; Fernández-Ruiz J
    Brain Res; 2006 Feb; 1073-1074():209-19. PubMed ID: 16412990
    [TBL] [Abstract][Full Text] [Related]  

  • 34. (R)-Methanandamide and delta9-tetrahydrocannabinol-induced operant rate decreases in rats are not readily antagonized by SR-141716A.
    Järbe TU; Lamb RJ; Liu Q; Makriyannis A
    Eur J Pharmacol; 2003 Apr; 466(1-2):121-7. PubMed ID: 12679148
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The synthetic cannabinoid HU210 induces spatial memory deficits and suppresses hippocampal firing rate in rats.
    Robinson L; Goonawardena AV; Pertwee RG; Hampson RE; Riedel G
    Br J Pharmacol; 2007 Jul; 151(5):688-700. PubMed ID: 17502849
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inhibition of milk ingestion and growth after administration of a neutral cannabinoid CB1 receptor antagonist on the first postnatal day in the mouse.
    Fride E; Braun H; Matan H; Steinberg S; Reggio PH; Seltzman HH
    Pediatr Res; 2007 Nov; 62(5):533-6. PubMed ID: 17805201
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Amnestic effect of intrahippocampal AM251, a CB1-selective blocker, in the inhibitory avoidance, but not in the open field habituation task, in rats.
    de Oliveira Alvares L; de Oliveira LF; Camboim C; Diehl F; Genro BP; Lanziotti VB; Quillfeldt JA
    Neurobiol Learn Mem; 2005 Mar; 83(2):119-24. PubMed ID: 15721795
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of the cannabinoid CB(1) receptor antagonist, SR141716A, after Delta(9)-tetrahydrocannabinol withdrawal.
    Beardsley PM; Martin BR
    Eur J Pharmacol; 2000 Jan; 387(1):47-53. PubMed ID: 10633159
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The effect of am 251, a cannabinoid CB1 receptor antagonist, on food intake in rats.
    Rutkowska M
    Acta Pol Pharm; 2004; 61(5):401-3. PubMed ID: 15747698
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Modulation of anxiety by acute blockade and genetic deletion of the CB(1) cannabinoid receptor in mice together with biogenic amine changes in the forebrain.
    Thiemann G; Watt CA; Ledent C; Molleman A; Hasenöhrl RU
    Behav Brain Res; 2009 Jun; 200(1):60-7. PubMed ID: 19162082
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.